Across TCGA pan-cancer cohorts, RNU6-774P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-774P data layer.
The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNU6-774P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-774P expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.
LAML, LUAD, and BLCA are the cancer types where RNU6-774P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.